Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9622667rdf:typepubmed:Citationlld:pubmed
pubmed-article:9622667lifeskim:mentionsumls-concept:C0006684lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C0494491lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C1153440lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:9622667lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:9622667pubmed:issue2lld:pubmed
pubmed-article:9622667pubmed:dateCreated1998-8-27lld:pubmed
pubmed-article:9622667pubmed:abstractTextWe investigated the effects of intrathecally administered N-type and P-type voltage-sensitive calcium channel (VSCC) blockers on the level of thermal hyperalgesia in two neuropathic pain models: the chronic constriction injury (CCI) model and the partial sciatic nerve injury (PSNI) model. N-type, but not P-type, VSCC blockers attenuated the level of thermal hyperalgesia induced by CCI in a dose-dependent manner. In the PSNI model, both N-type and P-type VSCC blockers had no effect on thermal hyperalgesia. This suggests that some types of neuropathic pain may be treatable with N-type VSCC blockers.lld:pubmed
pubmed-article:9622667pubmed:languageenglld:pubmed
pubmed-article:9622667pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:citationSubsetIMlld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9622667pubmed:statusMEDLINElld:pubmed
pubmed-article:9622667pubmed:monthJunlld:pubmed
pubmed-article:9622667pubmed:issn0006-8993lld:pubmed
pubmed-article:9622667pubmed:authorpubmed-author:YamamotoTTlld:pubmed
pubmed-article:9622667pubmed:authorpubmed-author:SakashitaYYlld:pubmed
pubmed-article:9622667pubmed:copyrightInfoCopyright 1998 Elsevier Science B.V. All rights reserved.lld:pubmed
pubmed-article:9622667pubmed:issnTypePrintlld:pubmed
pubmed-article:9622667pubmed:day1lld:pubmed
pubmed-article:9622667pubmed:volume794lld:pubmed
pubmed-article:9622667pubmed:ownerNLMlld:pubmed
pubmed-article:9622667pubmed:authorsCompleteYlld:pubmed
pubmed-article:9622667pubmed:pagination329-32lld:pubmed
pubmed-article:9622667pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:meshHeadingpubmed-meshheading:9622667-...lld:pubmed
pubmed-article:9622667pubmed:year1998lld:pubmed
pubmed-article:9622667pubmed:articleTitleDifferential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat.lld:pubmed
pubmed-article:9622667pubmed:affiliationDepartment of Anesthesiology, School of Medicine, Chiba University, Chiba 260-0856, Japan. yamatat@med.m.chiba-u.ac.jplld:pubmed
pubmed-article:9622667pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9622667pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9622667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9622667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9622667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9622667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9622667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9622667lld:pubmed